Antibody-drug conjugates (ADC) represent a novel and exciting  new treatment option for cancer. However, there are side effects that must be  discussed, including ocular side effects. This course discusses the mechanism of  action of ocular side effects of these drugs. We will review the common complaints,  proper diagnostic work up, common treatments, and typical follow up schedule. We  will also discuss what to report to the oncologist or hematologist so that eye care professionals can collaborate in patient care. Several case reports are presented.

Over 600 attended our event and we received amazing feedback!

Feedback from anonymous survey:

• I really enjoyed learning about a new topic to me (ADC’s). Thank you!!

• thank you! appreciated this rare topic, explained well.

• Excellent choice for a topic, and excellent speaker

• This wasn't a topic I thought would be very relevant to my practice specifically but it definitely was and I'm happy I attended!

• Very impressive speaker. Easy to understand.

• Gave clear recommendations and followup protocols.

• Fabulous speaker. His information was presented in a manner that made it easy to understand and very interesting. I would attend more CE lectures by him.

• This was a new topic for me. It was extremely interesting and informative. I do not believe I would see any of this patient population, but having this added knowlege is fantastic.

• very interesting topic. I really liked this speaker. He was right to the point.

Speaker: Dr. Saba K Al-Hashimi 

Thank you to ImmunoGen for supporting this event with unrestricted educational grant.

This event is COPE approved for 1 hour of CE credit.